Zygomycosis: Review of 16 cases;ZIGOMICOSIS: REVISION DE 16 CASOS

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 14, Issue 4, 1996, Pages 233-239

  González, Alejandro ^a   Del Palacio, Amalia ^a   Cuétara, Ma Soledad ^a   Gómez, César ^a   Carabias, Esperanza ^a   Malo, Quílez ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

amphotericin B; mucormycosis; zygomycosis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; MALE; MUCORMYCOSIS; RHIZOPUS; SPAIN; CASE REPORT; CHILD; COMORBIDITY; CROSS INFECTION; DIABETES MELLITUS; DISEASE PREDISPOSITION; FATALITY; IMMUNE DEFICIENCY; ISOLATION AND PURIFICATION; LEUKEMIA; LIVER DISEASE; MICROBIOLOGY; MIDDLE AGED; MUCORALES; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; REVIEW; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CHILD; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS INFECTION; DIABETES MELLITUS; DISEASE SUSCEPTIBILITY; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA; LIVER DISEASES; MALE; MIDDLE AGED; MUCORALES; MUCORMYCOSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RHIZOPUS; SPAIN; WOUND INFECTION;

EID: 0030113684     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. a. ed. Washington DC: American Society for Microbiology, 1985; 575-583.
2. Ajello L, Dean DJ, Irwin RS. The zygomicete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomicosis. Mycologia 1976; 68: 52-62.
3. Sands JM, Macher AM, Ley TJ, Nienhuis AW. Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalasemia. Case report and review of the literature. Ann Intern Med 1985; 102: 59-63.
4. Mostaza JM, Barbado FJ, Fernández Martín J, Peña Yáñez J, Vázquez Rodriguez JJ. Cutaneoarticular mucormycosis due to Cunninghamella bertholletiae in a patient with AIDS. Rev Infect Dis 1989; 11: 316-318.
5. Misra PC, Srivastava KJ, Lata K. Apophysomyces: a new genus of the mucorales. Mycotaxon 1979; 8: 377-382.
6. Cooter RD, Lim IS, Ellis DH, Leiten IOW. Burn wound zygomicosis by Apophysomyces elegans. J Clin Microbiol 1990; 28: 2.151-2.153.
7. Kamalam A, Thambia SS. Cutaneous infection by Synchephalastrum. Sabourandia 1980; 22: 273-277.
8. Lehrer RI, Howard DH, Sypherd PS, Edward JE, Segal GP, Winston DJ. Mucormycosis. Ann Intern Med 1980; 93: 93-108.
9. Del Palacio A, Romanyk J, García-Bravo M, Gimeno C, Lizasoain M, Lumbreras C, Ortiz-Romero P. Zygomicosis. A propósito de 4 casos. Actas Dermosifiliograf 1991; 82: 277-283.
10. Del Palacio A, Fereres J, Larregla S, Noriega AR, Sanz F. Nosocomial Infection by Rhizomucor pusillus in a clinical haematology unit. J Hosp Infect 1983; 4: 45-49.
11. Del Palacio A, Delgado JC, Bernaldo de Quirós A, Pérez A, Martín-Rabadán P. Cinco casos de zigomicosis en un hospital general. Estudio epidemiológico de un posible origen nosocomial. Rev Iber Micol 1987; 4: 135-148.
12. Del Palacio A, Martín P, Enriquez de Salamanca J, Díaz A, Nüñez-Reig A. Zigomicosis diseminada por Rhizopus oryzae. Colonización simultánea por Fusarium solani. Rev Esp Microbiol Clin 1987; 253-256.
13. González A, Del Palacio A, Lumbreras C, Rodríguez Peralto JL, Carabias E, Gómez C, Cuétara MS. Herida quirúrgica necrótica. Enferm Infecc Microbiol Clin 1995; 13: 435-436.
14. Shadomy S, Pfaller MA. Laboratory studies with antifungal agents: susceptibility tests and quantitation in body fluids. En: Balows A, Hausler WJ, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of Clinical Microbiology, 5 ed. Washington DC: American Society for Microbiology, 1991; 1.173-1.183.
15. Sugar AM. Mucormycosis. Clin Infect Dis 1992; 14: 126-129.
16. Del Palacio A. Zigomicosis. En: Torres Rodríguez JM, ed. Micología Médica. Barcelona: Ed Masson SA, 1993; 315-324.
17. a ed. Filadelfia: WB Saunders Co., 1982; 615-640.
18. Bolaert JR. Mucormycosis (zygomicosis): is there news for the clinician? J Infect 1994; 28: 1-6.
19. Pierce PF, Solomon SI, Kaufman L. Zygomicete brain abscesses in narcotic addicts with serological diagnosis. JAMA 1982; 248: 2.881-2.882.
20. Bolaert JR, De Locht M, Schneider YJ. The effect of deferoxamine on different Zygomicetes. J Infect Dis 1994; 169: 231-232.
21. Sheldon DL, Johnson WC. Cutaneous mucormycosis. Two document cases of suspected nosocomial cause. JAMA 1979; 241: 1.032-1.034.
22. Gartenberg G, Bottone EJ, Keusch GT, Wettman I. Hospital acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue. Engl J Med 1978; 299: 1.115-1.118.
23. St Germain G, Robert A, Ishak M, Tremblay C, Claveau S. Infection due to Rhizomucor pusillus: report of four cases in patients with leukaemia and review. Clin Infect Dis 1992; 16: 640-645.
24. Parfrey NA. Improved diagnosis and prognosis of mucormycosis. Medicine 1986; 65: 113-123.
25. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of Clinical Experience. Rev Infect Dis 1990; 12: 308-329.
26. Schmitt HJ. New methods of delivery of Amphotericin B. Clin Infect Dis 1993; 17: 501-506.
27. Meunier F. Alternative modalities of administering amphotericin B: current issues. J Infect 1994; 28: 51-56.
28. Hay RJ. Liposomal amphotericin B, AmBisome. J Infect 1994; 28: 35-43.
29. Ralph ED, Barber KR, Grant CWM. Clinical experience with multilamellar liposomal amphotericin B in patients with proven and suspected fungal infections. Scand J Infect Dis 1993; 25: 487-496.
30. Mackenzie DWR. Amphotericin B colloidal dispersion (ABCD) in the treatment of disseminated fungal Infections. Londres: Ed. Royal Society of Medicine Services, 1993.
31. Caillot D, Casanovas O, Solary E, Chavanet P, Bonnotte B, Reny G, Entezam F et al. Efficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients. Antimicrob Chemother 1993; 31: 161-169.
32. Caillot D, Chavanet P, Casanovas O, Solary E, Zanetta G, Buisson M, Wagner O et al. Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B. Eur J Clin Microbiol Infect Dis 1992; 11: 722-725.
33. Fisher EW, Toma A, Fisher PH, Cheesman AD. Rhinocerebral mucormycosis: use of liposomal amphotericin B. Laryngol Otology 1991; 105: 575-577.
34. Ericsson M, Anniko M, Gustafsson H, Hjalt CA, Stenling R, Tarvik A. A case of chronic progressive rhinocerebral mucormycosis treated liposomal amphotericin B and surgery. Clin Infect Dis 1993; 16: 585-586.
35. Ringden O, Meunier F, Tollemar J. Efficacy of amphotericin B encapsulated in liposomes in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 1991; 28: 73-82.
36. Munckhof W, Jones R, Tosolini FA, Marzec A, Angus P, Grayson ML. Cure of Rhizopus sinusitis in a liver transplant recipient with liposomal amphotericin B. Clin Infect Dis 1993; 16: 183.
37. Tkatch LS, Kusne S, Eibling D. Successful treatment of zygomicosis of the paranasal sinuses with surgical debridement and amphotericin B colloidal dispersion. Am J Otolaryngol 1993; 14: 249-253.
38. Oppenheim BA. Efficacy of amphotericin B colloidal dispersion (ABCD) in disseminated fungal infections (with particular reference to aspergillosis). En: Mackenzie DWR, ed. Amphotericin B colloidal dispersion (ABCD) in the treatment of disseminated fungal infections. Londres: Ed. Royal Society of Medicine Services, 1993; 57-67.
39. Persson U, Tennvall GR, Andersson S, Tyden G, Wettermark B. Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses. PharmacoEconomics 1992; 2: 500-508.